Company · CIK 0001316175
Anthera Pharmaceuticals Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001214659-18-004793 · 32.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-004587 · 32.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-004520 · 36.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-004181 · 19.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-003986 · 19.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001214659-18-003764 · 3.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-002834 · 18.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-002048 · 39.5 KBSEC(opens sec.gov)
- 10-KAnnual report0001214659-18-001789 · 8.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001214659-18-001788 · 136.2 KBSEC(opens sec.gov)
Insiders
- Bianchi AnnetteDirector
- Dickinson KlaraChief Regulatory Officer
- ENGLE STEVEN BDirector
- Fritsch UrsulaVP, Glob. Reg. & Compliance
- HEALY JAMESDirector
- HENNEY CHRISTOPHER SDirector
- Hislop ColinChief Medical Officer
- ISALY SAMUEL DDirector
- KILFOIL GEORGINASVP,Product Dev.& Project Mgmt
- Lau StephenVP, Corp. & Business Dev.
Tickers
No tickers on record.
Addresses
business
25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD, CA, 94545
mailing
25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD, CA, 94545
Same industry